I don't know shit about fuck.
I do know that
@Goldenrod wrote out an answer that I agree with every word of and additionally I would tell
@Musclemaker not to freeze it at any point.
I don't know what exact product
@BanditNOLIMIT has but If I was to hazard a guess I'd say it is likely Somatropin.
I do know that such products made by big pharma need to submit an approved Product Monograph to be allowed to sell them in a lot of countries.
I also know that these monographs often contain flagrant bullshit because big pharma is top heavy with scumbags so "Let the buyer beware" and consider whether it would be in their interest to get this part right or not.
From the Humatrope Monograph:
STORAGE AND STABILITY
Before Reconstitution: Vials of HUMATROPE (somatropin), HUMATROPE cartridges foruse with the HumatroPen and the supplied diluent for HUMATROPE are stable when stored at2° to 8°C. Avoid freezing the diluent for HUMATROPE. Expiration dates are stated on the labels.
After Reconstitution: When reconstituted with the supplied diluent and stored at 2° to 8°C: HUMATROPE vials are stable for up to 21 days and HUMATROPE cartridges for use with the HumatroPen are stable for up to 28 days Avoid freezing the reconstituted vials and cartridges of HUMATROPE.
If HUMATROPE vials are reconstituted with Sterile Water for Injection, USP, they should beused immediately after reconstitution. Although not recommended, the solution can be storedrefrigerated (2° to 8°C) but must be used within 24 hours. Discard any unused portion.
Light: Protect from light.
DOSAGE FORMS, COMPOSITION AND PACKAGING
HUMATROPE (somatropin) is a sterile, white, lyophylized powder of highly purified rhGH,which is intended for subcutaneous or intramuscular use after reconstitution with the supplieddiluent. HUMATROPE is available as a vial and cartridges (Table 8).
HUMATROPE Vials
Each vial of HUMATROPE contains 5 mg of somatropin for injection, in addition to mannitol,glycine, and dibasic sodium phosphate. Phosphoric acid and/or sodium hydroxide may have beenused for pH adjustment.
Each vial of HUMATROPE is supplied in a combination pack with an accompanying vial ofdiluting solution. The diluent for HUMATROPE contains water for injection with 1.7% glycerinand 0.3% metacresol as a preservative. At a concentration of 2 mg HUMATROPE per mLdiluent, the 1.7% glycerin makes the reconstituted product nearly isotonic. Reconstitutedsolutions have a pH of approximately 7.5.